← Back to Clinical Trials
Recruiting NCT04725422

CHronic Nonbacterial Osteomyelitis International Registry

Trial Parameters

Condition Chronic Nonbacterial Osteomyelitis
Sponsor Seattle Children's Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age N/A
Max Age 21 Years
Start Date 2018-08-01
Completion 2028-08
Interventions
MethotrexateSulfasalazineLeflunomide

Brief Summary

The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 years.

Eligibility Criteria

Inclusion Criteria: * \- Age at enrollment is equal to or younger than 21 years of age * Presence of bone edema on STIR or T2 fat saturation sequence on MRI within 12 weeks of enrollment * Whole body imaging evaluation (either WB MRI or bone scintigraphy) * Bone biopsy to exclude infection or malignancy unless bone lesions follow typical distribution or there is IBD, psoriasis, or palmar plantar pustulosis Exclusion Criteria: * \- History of or current malignancy * Current infectious osteomyelitis * Contraindication to the selected treatment agent

Related Trials